Key facts
- This page summarizes Robert G. Shawah's Form 4 filing for Acurx Pharmaceuticals, Inc. (ACXP).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 03 Apr 2024, 21:56.
Robert G. Shawah - 23 Feb 2024 Form 4 Insider Report for Acurx Pharmaceuticals, Inc. (ACXP)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- ACXP
- Reported as of
- 23 Feb 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Apr 2024, 21:56:25 UTC
- Prior SEC filing
- 24 Feb 2023
- Next SEC filing
- 06 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kostantinos Skordalos, Power of Attorney For: Robert G. Shawah
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert G. Shawah filed Form 4 for Acurx Pharmaceuticals, Inc. (ACXP) on 03 Apr 2024.
Change
- Previous filing in this sequence was filed on 24 Feb 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ACXP
transaction
Derivative
Stock Option
Award
- Transaction value
- $0
- Shares
- +145,000
- Change %
- Price
- $0.000000
- Shares after
- 145,000
- Date
- 23 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 145,000
- Exercise price
- $3.15
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
On February 23, 2024 (the "Grant Date"), the Reporting Person was granted stock options to purchase 145,000 shares of the Issuer's common stock. These options vest in 36 equal monthly installments commencing on the Grant Date. This transaction is late due to an inadvertent administrative error and not any error of the Reporting Person.